Eli Lilly’s Renee Williams arrived in New York City this week ready to mix and mingle with dozens of biotechs that had descended on the Big Apple itching to strike a deal. | With few avenues available to budding biotechs looking for funding, the pressure to ink licensing agreements was palpable at the Biotechnology Innovation Organization’s CEO and Investor Conference in New York.
BIO: Big Pharma offers menu of partnering options, but biotechs want licensing entrée
Date:
More like thisRelated
Fed will lower charges by 25bps in December, count on slower easing in 2025- UBS By Investing.com
Investing.com-- The Federal Reserve is prone to lower rates...